about
Management of borderline and locally advanced pancreatic cancer: where do we stand?New challenges in perioperative management of pancreatic cancerIncreased precision of orthotopic and metastatic breast cancer surgery guided by matrix metalloproteinase-activatable near-infrared fluorescence probesPrognostic value of the lymph node ratio after resection of periampullary carcinomas.Whipple made simple for surgical pathologists: orientation, dissection, and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of pancreatic, distal common bile duct, and ampullary tumors.Neoadjuvant chemotherapy for pancreatic cancer: Effects on cancer tissue and novel perspectives.Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191Predictors of survival in periampullary cancers following pancreaticoduodenectomy.Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Radiologic and intraoperative detection of need for mesenteric vein resection in patients with adenocarcinoma of the head of the pancreasPathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.Impact of Resection Margin Distance on Survival of Pancreatic Cancer: A Systematic Review and Meta-Analysis.A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol.Postoperative Outcomes of Enucleation and Standard Resections in Patients with a Pancreatic Neuroendocrine Tumor.An anatomical-based mapping analysis of the pancreaticoduodenectomy retroperitoneal margin highlights the urgent need for standardized assessment.Innovations in macroscopic evaluation of pancreatic specimens and radiologic correlation.Computed tomography-based diagnostics might be insufficient in the determination of pancreatic cancer unresectabilityComparison of Uncinate Process Cancer and Non-Uncinate Process Pancreatic Head Cancer.Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer.uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.Friday, February 21, 2014, 5:00pm–6:30pm Oral Poster I (Liver I, II; Pancreas I, II; Biliary I; Transplant I; Other)Peripancreatic soft tissue involvement: independent outcome predictor in patients with resected pancreatic adenocarcinoma.Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation.Potential epigenetic biomarkers for the diagnosis and prognosis of pancreatic ductal adenocarcinomas.Pancreaticoduodenectomy with vascular resection for pancreatic head adenocarcinoma.The importance of surgical margins in pancreatic cancer.Reporting the margin in pancreaticoduodenectomies: R0 versus R1.Endoluminal and Interstitial Brachytherapy for the Treatment of Gastrointestinal Malignancies: a Systematic Review.Induction Chemotherapy Followed by Resection or Irreversible Electroporation in Locally Advanced Pancreatic Cancer (IMPALA): A Prospective Cohort Study.Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up.Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Proposal for a Revised N Classification for TNM Staging.Does long-term survival in patients with pancreatic cancer really exist? Results from the CONKO-001 study.Tumor-positive resection margins reflect an aggressive tumor biology in pancreatic cancer.Tumor infiltration in the medial resection margin predicts survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.Redefining the Positive Margin in Pancreatic Cancer: Impact on Patterns of Failure, Long-Term Survival and Adjuvant Therapy.Surgical margins for duodenopancreatectomy.Is pancreatectomy with arterial reconstruction a safe and useful procedure for locally advanced pancreatic cancer?Retrospective comparison of robot-assisted minimally invasive versus open pancreaticoduodenectomy for periampullary neoplasms.Dilemmas for the pathologist in the oncologic assessment of pancreatoduodenectomy specimens : An overview of different grossing approaches and the relevance of the histopathological characteristics in the oncologic assessment of pancreatoduodenectomLocally advanced pancreatic duct adenocarcinoma: pancreatectomy with planned arterial resection based on axial arterial encasement.
P2860
Q26825414-2688092A-3273-4DB7-91FF-11742A102B1AQ28082422-43E38473-385A-49A1-970B-EF5C13D5ACECQ30665907-9519DD45-C89F-4102-9AF9-FE933B3EE899Q33720957-491EC294-1C1F-48EA-8A25-3575EA5966C3Q33732158-1C10227D-498F-45DE-ABE1-314D29CC6271Q33751263-66789E69-CF92-4517-838A-ED3F31206662Q33755147-5F08E376-0F6C-422F-A0A9-A2D3D98B673CQ33819380-65E278C7-312A-4CDE-9FA0-640707A4405DQ34301038-A9041B8F-0800-4083-BAE0-FC50AD70D2E3Q35244224-50655EDA-3AF5-4C83-A0F3-40A869DC787EQ36055277-A0B2600B-860C-420F-931B-E1824B23B329Q36113317-308FA83D-76A5-4631-B371-94926E13FEBAQ36130588-2330EB6A-8DDF-4361-B40A-1A98849EF265Q36558826-179900C7-4F46-4F5E-8EF7-6F212A9BC740Q36609378-23E1A288-1BBF-48EC-8243-191F868B80CBQ36740066-F3F4E8AB-A8C0-4992-9068-8EF188CFFD90Q36876409-422BEEE5-3301-44E0-BC6A-E0955569780CQ37067996-7A2852C6-E196-4F11-AD94-84E8FDD6DC7DQ37401414-58683874-ADBA-44BE-8349-9F8E0B73D20FQ37435242-ED0C7DE3-5C82-4C53-9B50-BA6FB2EB9752Q37480826-55BA4638-E058-4674-9A25-CC8135461D3AQ37499093-548932E9-7318-432D-8C56-DBD462D1A840Q37525315-C7D8488A-0784-4C71-A187-C9D020518331Q38115619-D7CDA212-9B2B-4EB2-BE25-C14999044F7AQ38212152-282FFF8E-D05B-44A2-80A5-1A592E17CF55Q38646898-9DCD3486-9788-4AAC-94D3-03F9D571ED8DQ38833318-CC379BD4-95D2-4C5D-A162-031B02ACD00CQ39097817-D50E2D8E-0AB1-4723-8D6F-43D673DFAAF5Q40179597-2DDDD020-AC00-4B28-A884-9D6BC617EAD9Q40776257-8719A9A0-2B24-499D-8AA3-FD9E0D638F8AQ41371326-6214CEC4-E545-4E89-A4B4-3FCC12E3C13CQ44369668-F31953AB-BF46-4158-A95B-C81F660AB476Q45217822-0F050FD1-5851-4525-8FC1-42B4567EAD26Q47282943-3C0476AD-591B-4F58-9FCC-6F21F788EB3FQ48035210-AB5AFAAD-62EF-443A-901E-EE8BA5FD6B2DQ48278023-B1740F69-B3A3-45A3-A35A-3188089B3117Q48985637-795F9508-F69A-4FEC-9708-7A73B0A37CFFQ50709385-5D8BCA55-896F-4CBC-A441-286885E7F6CFQ52339747-14944E3B-8E89-4033-8AE7-E7BC8F2DE744Q53058990-91A2BA47-D94D-4810-8C20-A7A210E203E6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Redefining resection margin status in pancreatic cancer
@en
Redefining resection margin status in pancreatic cancer.
@nl
type
label
Redefining resection margin status in pancreatic cancer
@en
Redefining resection margin status in pancreatic cancer.
@nl
prefLabel
Redefining resection margin status in pancreatic cancer
@en
Redefining resection margin status in pancreatic cancer.
@nl
P2860
P1476
Redefining resection margin status in pancreatic cancer
@en
P2093
Krishna V Menon
P2860
P304
P356
10.1111/J.1477-2574.2009.00055.X
P50
P577
2009-06-01T00:00:00Z